Enanta Pharmaceuticals | Deudores Comerciales

Trade Debtors Cambio Fecha
AbbVie USD 11.41B 79M 2023-09
Amgen USD 7.27B 1.12B 2023-12
Arrowhead Research USD 1.25M 68.19M 2023-06
AstraZeneca USD 12B 65M 2023-09
Biogen USD 2.1B 109.7M 2023-12
Bristol-Myers Squibb USD 15.65B 588M 2023-09
Gilead Sciences USD 4.66B 130M 2023-12
GlaxoSmithKline GBP 8.87B 1.78B 2023-09
Halozyme Therapeutics USD 234.21M 16.88M 2023-12
Incyte USD 743.56M 86.29M 2023-12
Insmed USD 41.19M 5.61M 2023-12
Ionis Pharmaceuticals USD 97.78M 44.58M 2023-12
Ligand Pharmaceuticals USD 39.31M 3.31M 2023-12
Merck USD 11.49B 263M 2023-09
Neurocrine Biosciences USD 417.8M 30.2M 2023-09
Pfizer USD 15B 1.58B 2023-09
PTC Therapeutics USD 160.82M 4.9M 2023-12
Roche Holding CHF 11.36B 560M 2023-06
Sarepta Therapeutics USD 354.26M 87.1M 2023-09
Vertex Pharmaceuticals USD 1.54B 17.5M 2023-09



Enanta Pharmaceuticals Deudores Comerciales - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2024.